Equity Follow-ons Set to Price
Chile’s Cencosud and Brazil’s Brazil Pharma are set to test equity investor appetite through follow-ons pricing today. Bankers, investors and analysts expect follow-ons and some of the larger IPOs to get done. Cencosud is offering 91.3m shares in the form of ADS, a sale that would raise CLP293.06bn ($586m) at Wednesday’s CLP2,791 closing price, assuming the use of a...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.